Literature DB >> 9038935

Alterations in sarcoplasmic reticulum calcium-storing proteins in pressure-overload cardiac hypertrophy.

H Tsutsui1, Y Ishibashi, K Imanaka-Yoshida, S Yamamoto, T Yoshida, M Sugimachi, Y Urabe, A Takeshita.   

Abstract

The alterations of intracellular calcium (Ca2+) homeostasis may be responsible for the contractile defects in pressure-overload cardiac hypertrophy. The Ca(2+)-adenosinetriphosphatase (ATPase) protein level of the sarcoplasmic reticulum (SR) is reduced in the hypertrophied or failing heart. However, it is not known whether Ca(2+)-storing proteins, including calsequestrin and calreticulin, are also altered during cardiac hypertrophy. We quantified SR Ca(2+)-regulatory proteins using Western blot analysis in left ventricular (LV) muscle isolated from sham-operated control rats (n = 6) and rats with pressure overload 4 wk after abdominal aortic constriction (n = 7). The contractile function of isolated LV myocytes, assessed by the sarcomere motion measured with laser diffraction, was depressed in aortic-constricted rats. The SR Ca(2+)-ATPase protein level was decreased to 56 +/- 9% (SE) of the control value in hypertrophied myocardium (P < 0.01). The calsequestrin protein level was not altered, whereas calreticulin was increased by 120 +/- 3% of the control value in aortic-constricted rats (P < 0.05). The alterations in SR Ca(2+)-regulatory proteins were equally observed in hypertrophied hearts even when the results were normalized using the amounts of myosin heavy chain proteins in each sample. Immunohistochemical staining of calsequestrin in the control heart showed cross striations at the Z lines, whereas calreticulin was hardly observed within myocytes but was intense within interstitial fibroblasts. In the hypertrophied heart, calreticulin was observed at the perinuclear region within the myocyte cytoplasm. These data indicate that pressure-overload cardiac hypertrophy causes the alterations in SR Ca(2+)-storing proteins as well as in Ca(2+)-ATPase, which may contribute to the contractile dysfunction of the hypertrophied myocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9038935     DOI: 10.1152/ajpheart.1997.272.1.H168

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Evidence for calreticulin attenuation of cardiac hypertrophy induced by pressure overload and soluble agonists.

Authors:  Sylvia Papp; Ewa Dziak; Golam Kabir; Peter Backx; Sophie Clement; Michal Opas
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

2.  Regulation of microRNA expression in the heart by the ATF6 branch of the ER stress response.

Authors:  Peter J Belmont; Wenqiong J Chen; Donna J Thuerauf; Christopher C Glembotski
Journal:  J Mol Cell Cardiol       Date:  2012-02-01       Impact factor: 5.000

3.  Increased activation of stromal interaction molecule-1/Orai-1 in aorta from hypertensive rats: a novel insight into vascular dysfunction.

Authors:  Fernanda R C Giachini; Chin-Wei Chiao; Fernando S Carneiro; Victor V Lima; Zidonia N Carneiro; Anne M Dorrance; Rita C Tostes; R Clinton Webb
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

4.  Novel proteins associated with human dilated cardiomyopathy: selective reduction in α(1A)-adrenergic receptors and increased desensitization proteins.

Authors:  Ting Shi; Christine S Moravec; Dianne M Perez
Journal:  J Recept Signal Transduct Res       Date:  2013-02-06       Impact factor: 2.092

5.  Calreticulin in the heart.

Authors:  Marek Michalak; Lei Guo; Murray Robertson; Mira Lozak; Michal Opas
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

6.  Calreticulin induces dilated cardiomyopathy.

Authors:  Dukgyu Lee; Tatsujiro Oka; Beth Hunter; Alison Robinson; Sylvia Papp; Kimitoshi Nakamura; Wattamon Srisakuldee; Barbara E Nickel; Peter E Light; Jason R B Dyck; Gary D Lopaschuk; Elissavet Kardami; Michal Opas; Marek Michalak
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

7.  Calreticulin signals upstream of calcineurin and MEF2C in a critical Ca(2+)-dependent signaling cascade.

Authors:  Jeffrey Lynch; Lei Guo; Pascal Gelebart; Kaari Chilibeck; Jian Xu; Jeffery D Molkentin; Luis B Agellon; Marek Michalak
Journal:  J Cell Biol       Date:  2005-07-04       Impact factor: 10.539

8.  miR-1283 Contributes to Endoplasmic Reticulum Stress in the Development of Hypertension Through the Activating Transcription Factor-4 (ATF4)/C/EBP-Homologous Protein (CHOP) Signaling Pathway.

Authors:  Weihao Chen; Tianhao Liu; Qiuer Liang; Xudong Chen; Wencong Tao; Meixia Fang; Ya Xiao; Liguo Chen
Journal:  Med Sci Monit       Date:  2021-04-29

9.  Delayed activation of the store-operated calcium current induced by calreticulin overexpression in RBL-1 cells.

Authors:  C Fasolato; P Pizzo; T Pozzan
Journal:  Mol Biol Cell       Date:  1998-06       Impact factor: 4.138

10.  Inhibition of the Unfolded Protein Response Mechanism Prevents Cardiac Fibrosis.

Authors:  Jody Groenendyk; Dukgyu Lee; Joanna Jung; Jason R B Dyck; Gary D Lopaschuk; Luis B Agellon; Marek Michalak
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.